Clin2
NCT07663838Possibly a fitNot yet recruiting

New vaginal gel for bacterial vaginosis

RandomizedOpen-labelSafetyTolerabilityPharmacokineticsBacterial Vaginosis

Part of Infections, Women’s health & pregnancy clinical trials.

This study tests a new vaginal gel for bacterial vaginosis (BV) in women aged 18-50. It aims to see if the gel is safe and works better than current treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 50 years old with a regular menstrual cycle (21-35 days).
  • You have been diagnosed with bacterial vaginosis (BV) and have symptoms like itching, odor, or discharge.
  • You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
  • You cannot have used any antibiotics or vaginal treatments for BV in the past month.
  • You must agree to avoid sexual intercourse, douching, tampons, or other vaginal products during the study.
  • You cannot have any other vaginal infections, chronic diseases, or conditions that might affect the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07483671Not yet recruiting· Phase 2
Study of BPR-101 capsules with metronidazole for bacterial vaginosis

This trial tests a combination of BPR-101 capsules (a probiotic) and an antibiotic (metronidazole) for women with bacterial vaginosis (BV). The goal is to see if this combination is more effective and safe than standard treatment alone.

Tianjin
NCT07302035Not yet recruiting· Phase 1
Safety study of a single vaginal dose in healthy women

This trial tests a single dose of an investigational drug given vaginally to healthy Chinese women. It aims to see if the drug is safe and how the body processes it.

Shanghai, Shanghai Municipality
NCT06450990Not yet recruiting· Phase 1/Phase 2
Testing a probiotic for vaginal infections

This trial tests a new live biotherapeutic product (a kind of probiotic) to treat bacterial vaginosis or yeast infections. It compares different doses to see which works best and is safest for relieving symptoms.

NCT07234786Recruiting
Vaginal gel for treating and preventing vaginal infections

This trial tests a vaginal gel to treat and prevent common vaginal infections like yeast infections (VVC) and bacterial vaginosis (BV). It may help if you currently have symptoms like itching, discharge, or odor.

Quatre Bornes
NCT07703241Not yet recruiting
Vaginal ovule for bacterial vaginosis and yeast infection

This trial tests a vaginal ovule (a small insert) medical device to treat bacterial vaginosis and yeast infections. It aims to see if the device is safe and effective at relieving symptoms like discharge, itching, and burning.

Naples
NCT07527572Not yet recruiting· Phase 2/Phase 3
Gyntima Balance to prevent recurring bacterial vaginosis

This study tests whether a probiotic product called Gyntima Balance can help prevent bacterial vaginosis (BV)—a common vaginal infection—from coming back repeatedly. If it works, it could reduce uncomfortable symptoms and the need for repeated antibiotic treatments.

Hear when a new Randomized trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.